Company profile
ABOUT HAEMOCAP MULTISITE
Description of Haemocap Multisite pressure dressing with application video and benefits.
Financial period: 1 Oct 2023 to 30 Sep 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
CS01 | Transaction MzQ0NDU4MjQ0MmFkaXF6a2N4
Published 22 Nov 2024 11:33
Last accounts made up date
AA | Transaction MzQzNjg1NzM3MmFkaXF6a2N4
Published 23 Sep 2024 02:07
Company registered at Companies House
1 Jun 2020 to 31 Mar 2021
Deep vein thrombosis (DVT) is a leading cause of death for hospitalised patients. The clot moves from the veins in the calf, travels in the venous system to the veins of the lungs causing a pulmonary embolism which starves the body of oxygenated blood and thus can cause death. Patients who are at more risk of a DVT include immobile patients, postoperative...
1 Sep 2017 to 31 Aug 2018
Deep Vein Thrombosis (DVT) is a major cause of morbidity and mortality that is well recognised. Current intermittent compression devices have several major drawbacks. This feasibility project will help develp a device called Haemopulse. Features include, portability, improved patient compliance, less variabilty of pressures generated and lower cost to man...
